| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | 8.170 | 21.590 | 26.415 | 22.296 | 21.129 | 24.716 | 18.430 | 20.298 |
| Total Income - EUR | - | - | 8.170 | 21.590 | 26.415 | 22.296 | 21.129 | 24.716 | 18.430 | 32.470 |
| Total Expenses - EUR | - | - | 691 | 10.214 | 25.193 | 29.450 | 27.949 | 24.114 | 18.048 | 30.084 |
| Gross Profit/Loss - EUR | - | - | 7.479 | 11.377 | 1.222 | -7.154 | -6.819 | 601 | 383 | 2.387 |
| Net Profit/Loss - EUR | - | - | 7.234 | 10.735 | 429 | -7.658 | -7.306 | 16 | 221 | 1.491 |
| Employees | - | - | 0 | 0 | 0 | 1 | 1 | 0 | 1 | 1 |
Check the financial reports for the company - Timrad Obgin Medical Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | 0 | 68.713 | 50.516 | 33.011 | 16.099 | 2.510 | 1.820 | 1.131 |
| Current Assets | - | - | 7.397 | 1.599 | 11.899 | 8.075 | 7.525 | 12.789 | 14.882 | 9.255 |
| Inventories | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | - | - | 0 | 0 | 0 | 0 | 99 | 2.073 | 493 | 0 |
| Cash | - | - | 7.397 | 1.599 | 11.899 | 8.075 | 7.426 | 10.716 | 14.390 | 9.255 |
| Shareholders Funds | - | - | 7.278 | 17.879 | 17.963 | 9.964 | 2.437 | 2.461 | 2.674 | 4.150 |
| Social Capital | - | - | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | - | - | 119 | 52.433 | 44.452 | 31.122 | 21.187 | 12.837 | 14.028 | 6.235 |
| Income in Advance | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Timrad Obgin Medical Srl